IFPMA Covid-19 Günlük Bülteni – 4 Mayıs


Top news:

  • The European Commission virtual global pledging event has reached a target of $8bn/ €7.4 billion in its first day – the pledging marathon will last until end of May
  • WHO’s Dr Tedros calls for equal distribution of COVID-19 medical products at European Commission pledging event & NGOs likewise call on governments to take action to make sure COVID-19 tools are accessible for all
  • European Commission to launch three partnerships focusing on vaccines (led by CEPI & GAVI), treatments (led by the COVID-19 Therapeutics Accelerator) and diagnostics (led by FIND) respectively
  • FDA authorizes emergency use of remdesivir, while Gilead pledges to donate the first 1.5 million doses in the US
  • Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization & company ramps up manufacturing in Germany


  • EU Commission: Coronavirus Global Response: €7.4 billion raised for universal access to vaccines. Today, the Commission registered €7.4 billion, equivalent to $8 billion, in pledges from donors worldwide during the Coronavirus Global Response pledging event. This includes a pledge of €1.4 billion by the Commission. An overview of all the pledges per respective country can be found here. The Global Vaccines Summit that Gavi will organise on 4 June will mobilise additional funding to protect the next generation with vaccines.
  • IFPMA: Pharma Joins Global Pledge Committing to Work Together to Beat COVID-19. Today, the industry recommitted at the Coronavirus Global Response Pledging Marathon, to channel its innovation, mobilize its knowhow, pool its expertise and share its manufacturing capacity to help deliver new vaccines and different types of therapeutics to stop the spread of pandemic.
  • Reuters: U.N. calls for COVID vaccine, treatment available for all at affordable prices at European Commission pledging conference. WHO DG, Dr Tedros stated that “the ultimate measure of success will not be how fast we can develop tools. It will be how equally we can distribute them.” Dr Tedros’ statement (via video) to the EU Commission’s pledging event can be found here.

NGO voices






  • Financial Times: Global stocks drop as US-China tension flares. The falls came after Mike Pompeo, US secretary of state, on Sunday reiterated US government claims linking the coronavirus outbreak to a laboratory in Wuhan, China, without providing any evidence. China has denied the allegations.


IFPMA members


  • Fierce Pharma: Lilly-partnered AbCellera gets COVID-19 boost from Canadian government. AbCellera said it will get up to $175.6 million in support from the government of Canada. This money will be used to “expand efforts related to the discovery of antibodies for use in drugs to treat COVID-19” as well as to build out new tech and manufacturing infrastructure for antibody therapies “against future pandemic threats.”
  • 7 News Australia: Stem cell treatment for virus patients to be trialled in Sydney. Executive Director Professor Jason Kovacic of Sydney’s Victor Chang Cardiac Research Institute, says the institute will work on a local clinical trial of the treatment being explored by New York’s Mount Sinai Hospital after 9 out of 12 patients in the US administered with stem cells were able to come off a ventilator in 10 days.


IFPMA members



Statement at the media briefing by Dr Tedros here.

  • Today, leaders from 40 countries all over the world came together to support the ACT Accelerator through the COVID-19 Global Response International Pledging Event, hosted by the European Commission.
  • During today’s event, some €7.4 billion was pledged for research and development for vaccines, diagnostics and therapeutics.
  • WHO remains committed to working with all countries and partners to accelerate the development and production of vaccines, diagnostics and therapeutics, and to ensure their equitable distribution.
  • This is an opportunity for the world to come together to confront a common threat, but also to forge a common future; a future in which all people enjoy the right to the highest attainable standard of health – and the products that deliver that right.
  • Later this week, WHO will launch its updated Strategic Preparedness and Response Plan, which will provide an update of the resources WHO needs to support the international response and national action plans to the end of 2020.

Dr Tedros’ statement (video) to the EU Commission’s pledging event here.